Skip to content

Opening book details…

Can I read Network pharmacology to uncover potential anti-inflammatory and immunomodulatory constituents in Curcuma longa rhizome as complementary treatment in COVID-19 on EtoBox?

Network pharmacology to uncover potential anti-inflammatory and immunomodulatory constituents in Curcuma longa rhizome as complementary treatment in COVID-19 by Raden Bayu Indradi; Dian Ayu Eka Pitaloka; Suryani Suryani is a Medicine article available to read on EtoBox.

What is Network pharmacology to uncover potential anti-inflammatory and immunomodulatory constituents in Curcuma longa rhizome as complementary treatment in COVID-19 about?

The immune status of patients plays an essential role in COVID-19. Herbal medicine with immunomodulatory and anti-inflammatory effect could have potential as a complementary therapeutic along with modern medicine. This study aims to investigate the anti-inflammatory and immunomodulatory constituents of Curcuma longa (C. longa) and its possible mechanisms in COVID-19. We systematically sorted the biochemical of C. longa rhizome from literature and repository. Next, we investigated targets related to COVID-19 in the selected active phytochemical constituents and analyzed the possible mechanisms against COVID-19 and performed molecular docking with four essential target proteins in COVID-19 for further verification. Ten active phytochemical constituents of C. longa were predicted to interact with four protein targets. The epidermal growth factor was the most interacted protein targeted by Calebin A, curcumin, cyclocurcumin, demethoxycurcumin, turmeronol a, turmeronol b, caffeic acid, and quercetin. Interferon-gamma was performed as the most critical protein targeted by 4-hydroxycinnamic acid. Curcumin was also predicted to interact with toll-like receptor 4 and Ar-turmerone with angio

Who reads Network pharmacology to uncover potential anti-inflammatory and immunomodulatory constituents in Curcuma longa rhizome as complementary treatment in COVID-19?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Raden Bayu Indradi; Dian Ayu Eka Pitaloka; Suryani Suryani
Publisher
Pensoft Publishers
Published
2022
Language
EN
Field
Medicine (Life Sciences)

More by Raden Bayu Indradi; Dian Ayu Eka Pitaloka; Suryani Suryani

Browse all works by Raden Bayu Indradi; Dian Ayu Eka Pitaloka; Suryani Suryani